Department of Geriatric Medicine, Amager and Hvidovre Hospital, Copenhagen, Denmark.
Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Glostrup, Copenhagen, Denmark.
Arch Osteoporos. 2024 Aug 17;19(1):77. doi: 10.1007/s11657-024-01437-9.
Bone and muscle impairment, named osteoporosis and sarcopenia, may co-occur with age, and patients with both disorders might exhibit physical frailty. One-hundred sixty-three patients were included. 14.2% had both disorders and presented more frequent with previous fall, reduced daily activity level, walk/balance challenges, and need of walking aid, indicating overall frailty.
In older adults, sarcopenia (muscle impairment) and physical frailty may accompany osteoporosis (bone brittleness), yet osteoporosis is typically assessed without evaluating these conditions, even though coexistence may contribute to exacerbated negative health outcomes. We aimed at evaluating the prevalence of sarcopenia and impaired muscle domains in osteoporotic patients and explore the risk of osteosarcopenia from markers of physical frailty.
In Copenhagen, Denmark, osteoporotic patients aged 65 + were assessed cross-sectionally in 2018-2019. Evaluations included muscle mass, strength, and function; bone mineral density; and self-reported physical activity, fall, balance challenges, dizziness, and the need of walking aid. Low bone mass, low-energy fracture, or treatment with anti-osteoporotic medication defined patient with osteoporosis, and sarcopenia was defined by low muscle strength and mass. Osteosarcopenia was defined from the coexistence of both conditions.
One-hundred sixty-three patients with osteoporosis were included. Of those, 23 (14.2%) exhibited sarcopenia, hence osteosarcopenia. Hand-grip-strength, 30-s-chair-stand-test, relative-appendicular-lean-muscle-mass, and gait-speed were below cut-off levels in 21.0%, 30.9%, 28.8%, and 23.6% of the patients, respectively. Previous fall, activity level, walk and balance challenges, and need of walking aid were statistically (or borderline) significantly more often affected in the osteosarcopenic group compared with the solely osteoporotic. Logistic regression analysis, however, revealed that only the need for walking aid significantly increased the risk of an osteosarcopenia diagnosis (odds ratio 5.54, 95% CI (1.95-15.76), p < 0.01).
Sarcopenia and impaired muscle domains were frequent in osteoporotic patients, as were markers of physical frailty, indicating the need of thorough examination of osteoporotic patients.
在老年人中,肌肉减少症(肌肉功能障碍)和身体虚弱可能与骨质疏松症(骨骼脆弱)同时存在,但通常在评估骨质疏松症时不评估这些情况,尽管共存可能导致更严重的负面健康后果。我们旨在评估骨质疏松症患者中肌肉减少症和肌肉功能障碍的患病率,并探讨身体虚弱标志物与骨质疏松-肌肉减少症的风险关系。
在丹麦哥本哈根,2018-2019 年对年龄在 65 岁及以上的骨质疏松症患者进行了横断面评估。评估包括肌肉质量、力量和功能;骨矿物质密度;以及自我报告的身体活动、跌倒、平衡挑战、头晕和对助行器的需求。低骨量、低能量骨折或抗骨质疏松药物治疗定义为骨质疏松症患者,肌肉减少症定义为肌肉力量和质量低。骨质疏松-肌肉减少症定义为两种疾病同时存在。
共纳入 163 例骨质疏松症患者。其中 23 例(14.2%)存在肌肉减少症,因此存在骨质疏松-肌肉减少症。握力、30 秒坐站测试、相对四肢瘦体重和步速分别在 21.0%、30.9%、28.8%和 23.6%的患者中低于临界值。既往跌倒、活动水平、行走和平衡挑战以及对助行器的需求在骨质疏松-肌肉减少症组中明显更常见(或接近显著),与单纯骨质疏松症组相比。然而,逻辑回归分析显示,只有对助行器的需求显著增加了骨质疏松-肌肉减少症诊断的风险(优势比 5.54,95%CI(1.95-15.76),p<0.01)。
骨质疏松症患者中肌肉减少症和肌肉功能障碍很常见,身体虚弱的标志物也很常见,这表明需要对骨质疏松症患者进行全面检查。